Drug Database
HO

Hoe-285 (Hoe 285 / Brainorm / Albex 285)

✓ Approved

Sanofi S.A · 小分子 · 小分子

什么是 Hoe-285?

Hoe-285 是一种小分子,由Sanofi S.A研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intravenous (IV)、Oral (PO)。

药物档案

商品名Hoe 285, Brainorm, Albex 285
公司Sanofi S.A
药物类别小分子
给药途径Injectable (Others), Intravenous (IV), Oral (PO)
状态Approved

治疗适应症

Hoe-285 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Nervous system disordersDelayed ischaemic neurological deficit✓ Approved

相关研究文献

PubMedNPJ Parkinson's disease2026-11-18

Longitudinal resting-state EEG-based modeling predicts phenoconversion and delineates heterogeneity in isolated REM sleep behavior disorder.

Yook Soonhyun S, Shin Jung-Won JW, Noh Tae-Gon TG, Park Gilsoon G et al.

Isolated REM sleep behavior disorder is a high-risk prodromal syndrome for Lewy body diseases but highly heterogeneous. Neurophysiologic markers resolving this heterogeneity and predicting phenoconversion remain limited. We applied Subtype and Stage Inference (SuStaIn) modeling to longitudinal resting-state EEG from a prospective cohort of 285 participants. SuStaIn identified a progressive degenerative subtype (Subtype 2), characterized by delta/theta increases and lower MoCA scores, and a posterior beta-low subtype (Subtype 1), which was longitudinally unstable and of uncertain independent prognostic significance. Longitudinal validation demonstrated substantial subtype shifting in Subtype 1 and stage advancement predominantly in Subtype 2. In Kaplan-Meier analysis, subtype shifting and accelerated annual stage advancement (ΔStage≥2) identified individuals at exceptionally high phenoconversion risk with survival approaching 0-15% by 7.5 years. These findings extend SuStaIn beyond cross-sectional inference by incorporating longitudinal subtype-shifting and stage-advancement features to stratify prodromal heterogeneity and predict neurodegenerative progression.

PMID 43045738
阅读全文 →
PubMedJournal of school psychology2026-11-18

Greater diversity, faster change? The role of the educational setting in the development of advanced theory of mind among primary school children.

Smogorzewska Joanna J, Szumski Grzegorz G, Grygiel Paweł P

The aim of this study was to replicate and extend a previous study on the role of the educational setting in the development of advanced theory of mind (AToM). The previous study had shown that the children's AToM developed significantly faster in inclusive classes rather than the traditional type, which houses only typically developing students. We analysed longitudinal data on 614 typically developing children, who were learning in 24 inclusive (n = 285 children) and 21 traditional (n = 329) primary school classes. The children were followed for two years, from the first to the third grade. In the study discussed here, we were able to repeat the previous result while controlling for cognitive and social factors that are important for AToM development. Moreover, we demonstrated, at least to some extent, a possible mechanism behind the difference. In inclusive classrooms, teachers' practices are focused mostly on the development of AToM abilities among children with weaker skills, while in traditional education classrooms, teachers tend to work with children whose abilities are stronger.

PMID 43051750
阅读全文 →
PubMedInternational journal of legal medicine2026-11-18

Revisiting sex chromosome dosage variation as a biomarker for forensic age estimation.

Chen Anqi A, Yang Fan F, Liu Yanan Y, Yang Qi Q et al.

Accumulating evidence suggests that age-related sex chromosome alterations may be relevant to biological aging. However, their utility for forensic age estimation remains uncertain. This study evaluated the potential of sex chromosome dosage variation for age prediction, with further assessment of quantification methods and analytical strategies to improve predictive performance. Sex chromosome dosage was quantified by qPCR in blood samples from 258 females and 200 males, targeting X- and Y-specific AMEL sequences and the autosomal reference gene RPP30. Additional ddPCR measurements were obtained from 361 individuals (206 females and 155 males), including 285 individuals analyzed by both methods. Linear regression models were constructed using chromosome dosage metrics and evaluated by five-fold cross-validation. Although ddPCR yielded dosage estimates close to the expected theoretical values, it did not demonstrate better age prediction performance than qPCR. ddPCR-derived Y chromosome dosage showed a weak but statistically significant negative correlation with age. Neither chromosome loss metrics nor alternative normalization strategies improved predictive performance. These findings suggested that improved quantification and analytical strategies did not overcome the limited age-predictive value of sex chromosome dosage, highlighting the distinction between biological relevance and forensic utility when evaluating candidate molecular biomarkers.

PMID 43049810
阅读全文 →
PubMedJournal of imaging informatics in medicine2026-11-18

PanPrompt3D: A Prompt-Guided SAM-Based Framework for 3D Pancreatic Segmentation Across Multi-Sequence MRI.

Zheng Yifeng Y, Liu Yuanyuan Y, Zhang Yangfan Y, Qian Huiying H et al.

Accurate three-dimensional pancreatic segmentation is important for pancreatic assessment, treatment planning, and quantitative follow-up. However, most existing segmentation methods have been developed primarily for computed tomography, and their performance across clinically used magnetic resonance imaging (MRI) sequences remains less well characterized. We propose PanPrompt3D, a prompt-guided 3D segmentation framework adapted from SAM-Med3D for pancreatic MRI. PanPrompt3D combines a hybrid Transformer-CNN encoder, 3D triplet attention, volumetric prompt encoding, a 3D mask decoder, and a volume-aware hybrid loss incorporating explicit volumetric consistency. The model was evaluated on public T1-weighted (T1W) and T2-weighted (T2W) MRI data and an in-house cohort of 285 water-sequence examinations. With five-point prompts, PanPrompt3D achieved Dice scores of 81.66%, 85.03%, and 85.07% on water-sequence, T1W, and T2W MRI, respectively. Compared with SAM-Med3D under the same prompting protocol, paired Dice improvements were 4.70, 5.80, and 4.99 percentage points, respectively, with all three comparisons remaining statistically significant after Holm correction. PanPrompt3D also achieved R2 values above 0.9 between predicted and reference pancreatic volumes. Leave-one-sequence-out experiments showed reduced performance on unseen sequences, while external validation on CrossPan and AMOS demonstrated transfer to independent public MRI data, with a clear performance decrease on the unseen out-of-phase contrast. These findings support PanPrompt3D as a practical prompt-guided framework for multi-sequence pancreatic MRI segmentation while highlighting the remaining challenge of generalization to unseen contrasts.

PMID 43045885
阅读全文 →
PubMedJournal of cosmetic dermatology2026-11-18

A Sequential Treatment of Keloids: Multiple-Hole Punch Excision Combined With Superficial Radiation and Drug.

Gong Zhicheng Z, Jing Wenwen W, Zhang Zhenhua Z, Rao Wenbin W et al.

Dense and multiple keloids present significant therapeutic challenges due to their stubborn nature and high recurrence rates. Although various treatment options exist, optimizing current approaches and integrating them into a rational, systematic regimen for keloid management remains a difficult clinical problem. This study aims to establish an effective multimodal sequential treatment protocol for patients with dense, multiple keloids. A total of 87 patients with 285 keloid lesions were enrolled from September 2023 to April 2024. All cases underwent a sequential treatment: Stage I involved drug-assisted multiple-hole punch excision followed by adjuvant superficial radiotherapy; Stage II consisted of periodic intralesional injections of betamethasone and 5-fluorouracil. Clinical outcomes, recurrence, and adverse events were evaluated at 12-month follow-up. The POSAS and VSS scores were recorded at each time point. At 12 months post-treatment, marked improvement was achieved in 78 patients (89.66%), with improvement in 7 (8.04%) and ineffective results in 2 (2.30%). The POSAS and VSS scores were recorded before treatment and at follow-up points at 30, 60, 90, 180, and 360 days. All patients developed varying degrees of local hyperpigmentation within 2 months after Stage I of multi-hole punch excision. In 80.75% of cases, the hyperpigmentation resolved within 3 months following Stage I, with the longest duration of resolution being 12 months. During Stage I, four cases of localized ulcers and five instances of acute radiation dermatitis appeared. All adverse reactions were effectively alleviated. No other adverse reactions occurred. This sequential treatment protocol offers a practical, minimally invasive, and effective option for patients with multiple, dense keloids.

PMID 43047096
阅读全文 →
PubMedJCO oncology practice2026-11-18

Seeking to Project the 2050 Oncologists' Workforce Through Historical Regional Trends and Economic Stratification: Challenges and Findings.

Asaturyan Arkadi A, Badalyan Sergey S, Aghajanyan Arina A, Zohrabyan Davit D et al.

Global oncology workforce planning increasingly relies on predictive modeling. However, projections are sensitive to baseline stratification. Historical models often use broad geographic regions, which may obscure economic heterogeneity within regions. We aimed to analyze historical workforce trends and compare regional versus income-stratified models to quantify approximate 2050 oncologist workforce burden. We extracted oncologist workforce data from peer-reviewed literature, government and Ministry of Health reports, and data sets from professional societies and organizations. Cancer incidence and population projections used GLOBOCAN and UN sources. Workforce burden was defined as annual new cancer cases per clinical oncologist. Historical burden velocity was estimated using data from 2012 to 2022 to build projections. A regional model for geographic and economic models by World Bank income groups was analyzed. Retrospective analysis suggests certain regional divergence patterns, although it is limited by heterogeneous data collection and reporting around the world. Europe and Northern America (United States and Canada) appeared to exhibit relative stability: burden improved in Northern America and slightly increased in Europe, reaching 134 and 185 cases per oncologist with 2050 projections. Yet, historically, burden increased in Asia and Africa, reaching 729 and 627 cases/oncologist, respectively. Income-based analysis projected 285 cases/oncologist in high-income countries, 93 in upper-middle-income countries, 1,126 in lower-middle-income countries, and 8,732 in low-income countries (LICs)-a 14-fold increase when shifting from regional to economic projections while also revealing lower-than-expected burden in emerging economies. Income-based stratification suggests that workforce deficits in LICs may be masked by geographic averaging. Absolute workforce growth alone is insufficient. Future oncology workforce planning should include income-based stratification to accurately identify critical global capacity gaps.

PMID 43050635
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多Hoe-285